Why the study?
Are subclinical atherosclerosis, endothelial function, and inflammatory markers altered in patients with CKD stages 3 to 4 compared to controls?
Are subclinical atherosclerosis, endothelial function, and inflammatory markers altered in patients with CKD stages 3 to 4 compared to controls?
Patients with CKD stages 3 to 4 have increased subclinical atherosclerosis (bIMT) and inflammatory markers compared to controls, with eGFR being the best predictor of bIMT.
Answers are grounded in this paper and cite their sources.
bIMT elevation in CKD stages 3-4 supports further vascular phenotyping; leaves open prognostic value and need for longitudinal validation.
Different inflammatory markers, brachial artery flow-mediated dilatation (FMD), and brachial intima-media thickness (bIMT) were measured in 50 patients with chronic kidney disease (CKD) stages 3 to 4 with estimated glomerular filtration rate (eGFR) and 35 age- and gender-matched controls. The bIMT was significantly increased in the patients with CKD compared with controls (0.43 mm [0.42, 0.45] vs 0.34 mm [0.32, 0.36]; P < .001). There was no significant difference in FMD between the study groups (4.7% vs 5.3%; P = .56). There were significant correlations between bIMT and high-sensitive C-reactive protein, vascular cellular adhesion molecule 1, tumor necrosis factor, and interleukin 6 (P < .05). However, eGFR adjusted for age and gender was the best predictor of bIMT. In conclusion, bIMT and inflammatory markers were increased in patients with CKD compared with the controls. Furthermore, significant correlations between bIMT and inflammatory activity in patients with CKD were observed. The eGFR adjusted for age and gender was the best predictor of bIMT.
No takes yet. Share an insight, caveat, or question.
Ghanavatian et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: